- Home
- ATNM vs MOB Comparison
ATNM vs MOB Comparison
Compare ATNM & MOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- MOB
- Stock Information
- Founded
- ATNM 2000
- MOB 2008
- Country
- ATNM United States
- MOB Israel
- Employees
- ATNM N/A
- MOB N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- MOB Real Estate Investment Trusts
- Sector
- ATNM Health Care
- MOB Real Estate
- Exchange
- ATNM Nasdaq
- MOB Nasdaq
- Market Cap
- ATNM 50.2M
- MOB 53.1M
- IPO Year
- ATNM N/A
- MOB 2022
- Fundamental
- Price
- ATNM $1.58
- MOB $8.83
- Analyst Decision
- ATNM Strong Buy
- MOB Strong Buy
- Analyst Count
- ATNM 2
- MOB 1
- Target Price
- ATNM $4.50
- MOB $10.00
- AVG Volume (30 Days)
- ATNM 116.8K
- MOB 654.7K
- Earning Date
- ATNM 11-13-2025
- MOB 08-12-2025
- Dividend Yield
- ATNM N/A
- MOB N/A
- EPS Growth
- ATNM N/A
- MOB N/A
- EPS
- ATNM N/A
- MOB N/A
- Revenue
- ATNM N/A
- MOB $2,826,361.00
- Revenue This Year
- ATNM N/A
- MOB $142.38
- Revenue Next Year
- ATNM N/A
- MOB $99.99
- P/E Ratio
- ATNM N/A
- MOB N/A
- Revenue Growth
- ATNM N/A
- MOB N/A
- 52 Week Low
- ATNM $1.03
- MOB $1.04
- 52 Week High
- ATNM $2.41
- MOB $11.02
- Technical
- Relative Strength Index (RSI)
- ATNM 42.17
- MOB 58.57
- Support Level
- ATNM $1.56
- MOB $8.15
- Resistance Level
- ATNM $1.64
- MOB $11.01
- Average True Range (ATR)
- ATNM 0.06
- MOB 1.13
- MACD
- ATNM -0.01
- MOB -0.08
- Stochastic Oscillator
- ATNM 6.67
- MOB 42.46
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About MOB Mobilicom Limited
Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.